Indices
Nifty 5022,425.50−1.16% Nifty Bank54,193.00−1.33% BSE Sensex72,603.60−0.88% Nifty Financial Services24,313.40−1.40% BSE Bankex61,033.40−1.19% Nifty Midcap Select12,963.15−2.64% India VIX16.73+6.15%
Nifty 50
ADANIENT2,469.40−3.16% ADANIPORTS1,693.70−3.22% APOLLOHOSP7,579.50−0.33% ASIANPAINT2,266.40−0.81% AXISBANK1,204.90−0.59% BAJAJ-AUTO10,053.00−1.00% BAJAJFINSV1,643.20−2.07% BAJFINANCE920.00−2.35% BEL356.45−2.21% BHARTIARTL1,864.20−1.63% BSE3,208.70−1.72% CIPLA1,318.60−0.92% COALINDIA391.80−2.67% DRREDDY1,226.90−0.98% EICHERMOT6,963.50−1.71% ETERNAL311.95+2.46% GRASIM2,874.90−0.67% HCLTECH1,424.70+0.21% HDFCBANK694.10+0.01% HDFCLIFE517.30−2.09% HINDALCO862.55−2.60% HINDUNILVR1,785.10−2.36% ICICIBANK1,388.50−0.72% INDIGO4,504.40−2.08% INFY1,158.35+0.43% ITC256.90−0.77% JIOFIN203.63−3.40% JSWSTEEL1,194.20−2.11% KOTAKBANK430.90−1.40% LT3,604.50−0.93% M&M2,816.70−1.65% MARUTI11,056.00−1.02% MAXHEALTH816.05−0.12% NESTLEIND1,161.40−2.40% NTPC293.10−3.14% ONGC224.95−0.02% POWERGRID242.45−2.40% RELIANCE1,171.50−1.10% SBILIFE1,621.00−1.33% SBIN952.35−1.82% SHRIRAMFIN871.95−3.21% SUNPHARMA1,740.30−1.01% TATACONSUM950.20−1.00% TATASTEEL164.15−4.75% TCS2,540.10+1.32% TECHM1,791.40−2.06% TITAN4,216.50−3.07% TMPV260.75−3.43% TRENT2,689.80−3.10% ULTRACEMCO10,862.00−0.88%
Sign in Get started

NATCO Pharma share price

NATCO Pharma Ltd. · NSE: NATCOPHARM · Healthcare

₹784.90 −0.25 −0.03%
Nifty 500Nifty PharmaSmall cap
Live · 23 Oct 2026, 12:38 IST

Price, one year

1 year agoLow 782.65 · High 1,206.00Latest close
1W+0.32%
1M−3.82%
3M−15.96%
6M−25.62%
1Y−6.51%

Price range

Open
₹785.00
High
₹789.20
Low
₹778.00
Previous close
₹785.15
Volume
3.2 L
Market cap
₹14,058 Cr
Day range
52-week range

Key statistics

Results to 30 Jun 2026 · Consolidated
P/E (TTM)
12.3
Price to book
1.5
Return on equity
12.4%
EPS (TTM)
₹63.89
Book value / share
₹514.83
Debt to equity
0.08
Revenue (TTM)
₹3,485 Cr
Net profit (TTM)
₹1,144 Cr
Sales growth, YoY
−44.7%
Profit growth, YoY
−57.0%
Operating margin
30.2%
Net margin
32.8%
Sales CAGR, 3 years
+14.6%
Profit CAGR, 3 years
+25.6%
Promoter holding
49.39%
Promoter shares pledged
0.00%
From the company's results filed with NSE; TTM is the last four quarters. Ratios use the latest price.

Shareholding pattern

% of shares
HolderSep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters49.4849.4849.4249.4249.39
Foreign institutions14.0915.1617.3716.9916.00
Domestic institutions5.875.395.465.626.16
Mutual funds2.201.601.721.922.25
Retail and others25.8425.3823.3323.4123.86

Results and announcements

Latest results (quarter to 30 Jun 2026) filed 14 Aug 2026.

  • 19 Oct 2026 · Press release
    Press Release
    Natco Pharma Limited has informed the Exchange regarding a press release dated October 19, 2026, titled "NATCO announces launch of Carboplatin Injection (generic of Paraplatin®) in the U.S. market".
Exchange filings as published on NSE; routine filings are left out.

Peers in Healthcare

All Healthcare stocks
CompanyPriceChangeMarket capP/E
Sun Pharmaceutical IndustriesSUNPHARMA ₹1,740.30 −1.01% ₹4,17,556 Cr 34.9
Divi's LaboratoriesDIVISLAB ₹8,881.00 −3.07% ₹2,35,763 Cr 83.1
Torrent PharmaceuticalsTORNTPHARM ₹4,487.40 −2.77% ₹1,70,686 Cr 73.7
Zydus LifesciencesZYDUSLIFE ₹1,123.50 −1.01% ₹1,12,070 Cr 25.3
Apollo Hospitals EnterpriseAPOLLOHOSP ₹7,579.50 −0.33% ₹1,08,982 Cr 52.3
CiplaCIPLA ₹1,318.60 −0.92% ₹1,06,526 Cr 31.9
Laurus LabsLAURUSLABS ₹1,943.30 −2.96% ₹1,04,999 Cr 98.8
Dr. Reddy's LaboratoriesDRREDDY ₹1,226.90 −0.98% ₹1,02,407 Cr 32.0
Mankind PharmaMANKIND ₹2,227.30 −2.12% ₹91,998 Cr 46.0
Aurobindo PharmaAUROPHARMA ₹1,557.70 −3.30% ₹89,627 Cr 25.2

Frequently asked questions

What is the share price of NATCO Pharma today?

NATCO Pharma (NSE: NATCOPHARM) was at ₹784.90 on 23 Oct 2026, a change of −0.03% from the previous close.

What are the 52-week high and low of NATCO Pharma?

Over the last 52 weeks NATCO Pharma traded between ₹773.60 and ₹1,226.80 (daily highs and lows on NSE on 23 Oct 2026).

What is the market capitalisation of NATCO Pharma?

About ₹14,058 Cr at the latest price, with a P/E of 12.3, a price-to-book of 1.5, a return on equity of 12.4%. Ratios use the company's latest reported results.

Who owns NATCO Pharma shares?

According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 49.39%, foreign institutions 16.00%, domestic institutions 6.16%.

Which sector and indices does NATCO Pharma belong to?

NSE classifies NATCO Pharma under Healthcare; it is a member of Nifty 500.

Follow NATCO Pharma with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.

Get started free